Author:
Mekala Janaki Ramaiah,Nalluri Hari P.,Reddy Prakash Narayana,S.B. Sainath,N.S. Sampath Kumar,G.V.S.D. Sai Kiran,Dhiman Rohan,Chamarthy Sahiti,Komaragiri Raghava Rao,Manyam Rajasekhar Reddy,Dirisala Vijaya R.
Reference288 articles.
1. Antibody–drug conjugates (ADCs) for cancer therapy: strategies, challenges, and successes;Abdollahpour-Alitappeh;J. Cell. Physiol.,2019
2. Acchione, M., Kwon, H., Jochheim, C.M., Atkins, W.M., 2012, May. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. In: MAbs, Vol. 4, No. 3. Taylor & Francis, pp. 362–372.
3. Clonal expansion of innate and adaptive lymphocytes;Adams;Nat. Rev. Immunol.,2020
4. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: case series of four critically ill patients treated with leronlimab;Agresti;J. Transl. Auto-immun.,2021
5. A review of margetuximab-based therapies in patients with HER2-positive metastatic breast cancer;Alasmari;Cancers,2023